Intraoperative hemorrhage as a complication of cesarean myomectomy: analysis of risk factors
Abstract
Background/Aim. Cesarean myomectomy is a controversial issue. It was considered relatively contraindicated for many years due to increased risk of intraoperative hemorrhage. Recent studies showed that cesarean myomectomy in some women may not be associated with increased morbidity. The aim of the study was to determine the causes and risk factors for intraoperative hemorrhage in patients subjected to cesarean myomectomy. Methods. This retrospective study included women subjected to cesarean myomectomy, divided into the study group of 36 patients in whom intraoperative hemorrhage was registered, and the control group of 66 patients in whom it was absent. The following parameters were analyzed: age, parity, gestational age of delivery, indications, type and duration of cesarean section, surgeon's experience, type, localization, size and number of myomas, number of incisions on uterus and neonatal birth weight. Results. There was a significant difference between the groups in terms of the type and size of myomas (p = 0.007 and p = 0.000, respectively) and duration of the surgery (p = 0.000). The size of the defect resulting from myoma enucleation and speed of suturing it have significant influence on the occurrence of intraoperative hemorrhage. In our study, operation on the patients of the study group lasted 14.53 minutes longer and their myomas were 39 mm bigger compared to the controls, with no difference in surgical experience of the obstetricians (p = 0.111). Conclusion. Cesarean myomectomy is associated with an increased risk of hemorrhage. Therefore, it would be advisable to discuss the hemorrhage and transfusion risks with patients with large multiple and intramural myomas before making decision to perform cesarean myomectomy. Those who perform cesarean myomectomy should be prepared to manage intraoperative hemorrhage during surgery in cases they encounter it.
References
Sparić R. Uterine myomas in pregnancy, childbirth and puer-perium. Srp Arh Celok Lek 2014; 142(1−2): 118−24. (Serbian)
Malvasi A, Stark M, Tinelli A. Cesarean myomectomy. In: Tinelli A, Malvasi A, editors. Uterine myoma, myomectomy and minimally invasive treatments. Berlin: Springer; 2015. p. 237−52.
Exacoustòs C, Rosati P. Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynecol 1993; 82(1): 97−101.
Incebiyik A, Hilali NG, Camuzcuoglu A, Vural M, Camuzcuoglu H. Myomectomy during caesarean: a retrospective evaluation of 16 cases. Arch Gynecol Obstet 2014; 289(3): 569−73.
Song D, Zhang W, Chames MC, Guo J. Myomectomy during ce-sarean delivery. Int J Gynecol Obstet 2013; 121(3): 208−13.
Tinelli A, Malvasi A, Mynbaev OA, Barbera A, Perrone E, Guido M, et al. The surgical outcome of intracapsular cesarean myo-mectomy. A match control study. J Matern Fetal Neonatal Med 2014; 27(1): 66−71.
Mahey R, Kriplani A. Cesarean myomectomy. AOGD Bulletin 2014; 13(10): 21−2.
Awoleke JO. Myomectomy during Caesarean Birth in Fibroid-Endemic, Low-Resource Settings. Obstet Gynecol Int 2013 14; 2013: 520834.
Lee HJ, Norwitz ER, Shaw J. Contemporary management of fi-broids in pregnancy. Rev Obstet Gynecol 2010; 3(1): 20−7.
Sparic R, Lazovic B. Inevitable cesarean myomectomy following delivery through posterior hysterotomy in a case of uterine torsion. Med Arch 2013; 67(1): 75−6.
Hassiakos D, Christopoulos P, Vitoratos N, Xarchoulakou E, Vaggos G, Papadias K. Myomectomy during cesarean section: a safe procedure. Ann N Y Acad Sci 2006; 1092: 408−13.
Kim Y, Choi S, Bae D. Risk factors for complications in patients undergoing myomectomy at the time of cesarean section. J Obstet Gynaecol Res 2010; 36(3): 550−4.
Ortaç F, Güngör M, Sönmezer M. Myomectomy during cesarean section. Int J Gynecol Obstet 1999; 67(3): 189−90.
Kumar RR, Patil M, Sa S. The utility of caesarean myomectomy as a safe procedure: a retrospective analysis of 21 cases with review of the literature. J Clin Diagn Res 2014; 8(9): OCO5−8.
Ehigiegba AE, Ande AB, Ojobo SI. Myomectomy during cesarean section. Int J Gynecol Obstet 2001; 75(1): 21−5.
Sultana R, Noor S, Nazar AF, Abbasi N, Bashir R, Khan B, et al. Safety of caesarean myomectomy. J Ayub Coll Abbottabad 2012; 24(2): 120−1.
Simsek Y, Celen S, Danisman N, Mollamahmutoğlu L. Removal of uterine fibroids during cesarean section: a difficult therapeutic decision. Clin Exp Obstet Gynecol 2012; 39(1): 76−8.
Häger RM, Daltveit AK, Hofoss D, Nilsen ST, Kolaas T, Øian P, et al. Complications of cesarean deliveries: rates and risk factors. Am J Obstet Gynecol 2004; 190(2): 428−34.
Seffah JD. Re-laparotomy after Cesarean section. Int J Gynecol Obstet 2005; 88(3): 253−7.
Burton CA, Grimes DA, March CM. Surgical management of leiomyomata during pregnancy. Obstet Gynecol 1989; 74(5): 707−9.
Kwawukume EY. Myomectomy during cesarean section. Int J Gynecol Obstet 2002; 76(2): 183−4.
Kaymak O, Ustunyurt E, Okyay RE, Kalyoncu S, Mollamahmutoglu L. Myomectomy during cesarean section. Int J Gynecol Obstet 2005; 89(2): 90−3.
Roman AS, Tabsh KM. Myomectomy at time of cesarean deliv-ery: a retrospective cohort study. BMC Pregnancy Childbirth 2004; 4(1): 14.
Skjeldestad FE, Oian P. Blood loss after cesarean delivery: a reg-istry-based study in Norway, 1999-2008. Am J Obstet Gyn 2012; 206(1): 1−7.
Sparić R, Lazović B, Sulović N, Buzadzić S. Our experience with intraoperative cell salvage during cesarean delivery in women with uterine myomas--four case reports. Med Pregl 2014; 67(3−4): 111−7.
Kunde K, Cortes E, Seed P, Khalaf Y. Evaluation of perioperative morbidity associated with single and multiple myomectomy. J Obstet Gynaecol 2009; 29(8): 737−41.
Fok WY, Chan LY, Chung TK. The effect of learning curve on the outcome of caesarean section. BJOG 2006; 113(11): 1259−63.
Bergholt T, Stenderup JK, Vedsted-Jakobsen A, Helm P, Lenstrup C. Intraoperative surgical complication during cesarean section: an observational study of the incidence and risk factors. Acta Obstet Gynecol Scand 2003; 82(3): 251−6.